Skip to main content

M 714 Pill - orange round

Pill with imprint M 714 is Orange, Round and has been identified as Risedronate Sodium 35 mg. It is supplied by Mylan Pharmaceuticals Inc.

Risedronate is used in the treatment of Prevention of Osteoporosis; Paget's Disease; Osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 714

Risedronate sodium 35 mg M 714 Front
Risedronate sodium 35 mg M 714 Back
Risedronate sodium 35 mg M 714
Risedronate sodium 35 mg M 714

Risedronate Sodium

M 714
35 mg
Prescription only
Drug Class
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-4714 (Discontinued)
Inactive Ingredients
silicon dioxide, magnesium stearate, mannitol, microcrystalline cellulose, polydextrose, titanium dioxide, ferric oxide red, triacetin, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "M 714"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.